APO Research
Talk to an analyst

APO RESEARCH · REPORT

Imipenem

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Imipenem Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchImipenem Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Imipenem Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Imipenem Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Imipenem Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Imipenem Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Imipenem market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Imipenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Imipenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Imipenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Imipenem is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Imipenem include Sun Pharmaceutical Industries, Haibin Pharmaceutical, Jiangxi Fushine Pharmaceutical, Savior Lifetec, HISUN Pharmaceutical and HISOAR, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Imipenem, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Imipenem, also provides the sales of main regions and countries. Of the upcoming market potential for Imipenem, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Imipenem sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Imipenem market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Imipenem sales, projected growth trends, production technology, application and end-user industry.

Imipenem Segment by Company

Sun Pharmaceutical Industries

Haibin Pharmaceutical

Jiangxi Fushine Pharmaceutical

Savior Lifetec

HISUN Pharmaceutical

HISOAR

Imipenem Segment by Type

Sterile Type

Non-sterile Type

Imipenem Segment by Application

Injection

Other

Imipenem Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Imipenem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Imipenem and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Imipenem.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Imipenem in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Imipenem manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Imipenem sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Imipenem Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sterile Type Major Manufacturers Table 3. Non-sterile Type Major Manufacturers Table 4. Global Imipenem Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Injection Major Manufacturers Table 6. Other Major Manufacturers Table 7. Imipenem Industry Trends Table 8. Imipenem Industry Drivers Table 9. Imipenem Industry Opportunities and Challenges Table 10. Imipenem Industry Restraints Table 11. Global Imipenem Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Imipenem Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Imipenem Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Imipenem Revenue Market Share by Region (2021-2026) Table 15. Global Imipenem Revenue Market Share by Region (2027-2032) Table 16. Global Imipenem Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 17. Global Imipenem Sales by Region (2021-2026) & (kg) Table 18. Global Imipenem Sales by Region (2027-2032) & (kg) Table 19. Global Imipenem Sales Market Share by Region (2021-2026) Table 20. Global Imipenem Sales Market Share by Region (2027-2032) Table 21. Global Imipenem Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Imipenem Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Imipenem Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Imipenem Sales Market Share by Manufacturers (2021-2026) Table 25. Global Imipenem Sales Price (US$/kg) of Manufacturers (2021-2026) Table 26. Global Imipenem Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Imipenem Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Imipenem Manufacturers, Product Type & Application Table 29. Global Imipenem Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Imipenem by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Imipenem Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Imipenem Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Imipenem Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Imipenem Revenue Market Share by Type (2021-2026) Table 36. Global Imipenem Revenue Market Share by Type (2027-2032) Table 37. Global Imipenem Sales by Type 2021 VS 2025 VS 2032 (kg) Table 38. Global Imipenem Sales by Type (2021-2026) & (kg) Table 39. Global Imipenem Sales by Type (2027-2032) & (kg) Table 40. Global Imipenem Sales Market Share by Type (2021-2026) Table 41. Global Imipenem Sales Market Share by Type (2027-2032) Table 42. Global Imipenem Price by Type (2021-2026) & (US$/kg) Table 43. Global Imipenem Price by Type (2027-2032) & (US$/kg) Table 44. Global Imipenem Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Imipenem Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Imipenem Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Imipenem Revenue Market Share by Application (2021-2026) Table 48. Global Imipenem Revenue Market Share by Application (2027-2032) Table 49. Global Imipenem Sales by Application 2021 VS 2025 VS 2032 (kg) Table 50. Global Imipenem Sales by Application (2021-2026) & (kg) Table 51. Global Imipenem Sales by Application (2027-2032) & (kg) Table 52. Global Imipenem Sales Market Share by Application (2021-2026) Table 53. Global Imipenem Sales Market Share by Application (2027-2032) Table 54. Global Imipenem Price by Application (2021-2026) & (US$/kg) Table 55. Global Imipenem Price by Application (2027-2032) & (US$/kg) Table 56. Sun Pharmaceutical Industries Company Information Table 57. Sun Pharmaceutical Industries Business Overview Table 58. Sun Pharmaceutical Industries Imipenem Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 59. Sun Pharmaceutical Industries Imipenem Product Portfolio Table 60. Sun Pharmaceutical Industries Recent Development Table 61. Haibin Pharmaceutical Company Information Table 62. Haibin Pharmaceutical Business Overview Table 63. Haibin Pharmaceutical Imipenem Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 64. Haibin Pharmaceutical Imipenem Product Portfolio Table 65. Haibin Pharmaceutical Recent Development Table 66. Jiangxi Fushine Pharmaceutical Company Information Table 67. Jiangxi Fushine Pharmaceutical Business Overview Table 68. Jiangxi Fushine Pharmaceutical Imipenem Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 69. Jiangxi Fushine Pharmaceutical Imipenem Product Portfolio Table 70. Jiangxi Fushine Pharmaceutical Recent Development Table 71. Savior Lifetec Company Information Table 72. Savior Lifetec Business Overview Table 73. Savior Lifetec Imipenem Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Savior Lifetec Imipenem Product Portfolio Table 75. Savior Lifetec Recent Development Table 76. HISUN Pharmaceutical Company Information Table 77. HISUN Pharmaceutical Business Overview Table 78. HISUN Pharmaceutical Imipenem Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. HISUN Pharmaceutical Imipenem Product Portfolio Table 80. HISUN Pharmaceutical Recent Development Table 81. HISOAR Company Information Table 82. HISOAR Business Overview Table 83. HISOAR Imipenem Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. HISOAR Imipenem Product Portfolio Table 85. HISOAR Recent Development Table 86. North America Imipenem Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Imipenem Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Imipenem Sales by Type (2021-2026) & (kg) Table 89. North America Imipenem Sales by Type (2027-2032) & (kg) Table 90. North America Imipenem Sales Price by Type (2021-2026) & (US$/kg) Table 91. North America Imipenem Sales Price by Type (2027-2032) & (US$/kg) Table 92. North America Imipenem Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Imipenem Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Imipenem Sales by Application (2021-2026) & (kg) Table 95. North America Imipenem Sales by Application (2027-2032) & (kg) Table 96. North America Imipenem Sales Price by Application (2021-2026) & (US$/kg) Table 97. North America Imipenem Sales Price by Application (2027-2032) & (US$/kg) Table 98. North America Imipenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Imipenem Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Imipenem Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Imipenem Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 102. North America Imipenem Sales by Country (2021-2026) & (kg) Table 103. North America Imipenem Sales by Country (2027-2032) & (kg) Table 104. North America Imipenem Sales Price by Country (2021-2026) & (US$/kg) Table 105. North America Imipenem Sales Price by Country (2027-2032) & (US$/kg) Table 106. United States Imipenem Revenue (2021-2032) & (US$ Million) Table 107. Canada Imipenem Revenue (2021-2032) & (US$ Million) Table 108. Mexico Imipenem Revenue (2021-2032) & (US$ Million) Table 109. Europe Imipenem Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Imipenem Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Imipenem Sales by Type (2021-2026) & (kg) Table 112. Europe Imipenem Sales by Type (2027-2032) & (kg) Table 113. Europe Imipenem Sales Price by Type (2021-2026) & (US$/kg) Table 114. Europe Imipenem Sales Price by Type (2027-2032) & (US$/kg) Table 115. Europe Imipenem Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Imipenem Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Imipenem Sales by Application (2021-2026) & (kg) Table 118. Europe Imipenem Sales by Application (2027-2032) & (kg) Table 119. Europe Imipenem Sales Price by Application (2021-2026) & (US$/kg) Table 120. Europe Imipenem Sales Price by Application (2027-2032) & (US$/kg) Table 121. Europe Imipenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Imipenem Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Imipenem Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Imipenem Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 125. Europe Imipenem Sales by Country (2021-2026) & (kg) Table 126. Europe Imipenem Sales by Country (2027-2032) & (kg) Table 127. Europe Imipenem Sales Price by Country (2021-2026) & (US$/kg) Table 128. Europe Imipenem Sales Price by Country (2027-2032) & (US$/kg) Table 129. Germany Imipenem Revenue (2021-2032) & (US$ Million) Table 130. France Imipenem Revenue (2021-2032) & (US$ Million) Table 131. U.K. Imipenem Revenue (2021-2032) & (US$ Million) Table 132. Italy Imipenem Revenue (2021-2032) & (US$ Million) Table 133. Russia Imipenem Revenue (2021-2032) & (US$ Million) Table 134. Spain Imipenem Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Imipenem Revenue (2021-2032) & (US$ Million) Table 136. Switzerland Imipenem Revenue (2021-2032) & (US$ Million) Table 137. Sweden Imipenem Revenue (2021-2032) & (US$ Million) Table 138. Poland Imipenem Revenue (2021-2032) & (US$ Million) Table 139. China Imipenem Revenue by Type (2021-2026) & (US$ Million) Table 140. China Imipenem Revenue by Type (2027-2032) & (US$ Million) Table 141. China Imipenem Sales by Type (2021-2026) & (kg) Table 142. China Imipenem Sales by Type (2027-2032) & (kg) Table 143. China Imipenem Sales Price by Type (2021-2026) & (US$/kg) Table 144. China Imipenem Sales Price by Type (2027-2032) & (US$/kg) Table 145. China Imipenem Revenue by Application (2021-2026) & (US$ Million) Table 146. China Imipenem Revenue by Application (2027-2032) & (US$ Million) Table 147. China Imipenem Sales by Application (2021-2026) & (kg) Table 148. China Imipenem Sales by Application (2027-2032) & (kg) Table 149. China Imipenem Sales Price by Application (2021-2026) & (US$/kg) Table 150. China Imipenem Sales Price by Application (2027-2032) & (US$/kg) Table 151. Asia Imipenem Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Imipenem Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Imipenem Sales by Type (2021-2026) & (kg) Table 154. Asia Imipenem Sales by Type (2027-2032) & (kg) Table 155. Asia Imipenem Sales Price by Type (2021-2026) & (US$/kg) Table 156. Asia Imipenem Sales Price by Type (2027-2032) & (US$/kg) Table 157. Asia Imipenem Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Imipenem Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Imipenem Sales by Application (2021-2026) & (kg) Table 160. Asia Imipenem Sales by Application (2027-2032) & (kg) Table 161. Asia Imipenem Sales Price by Application (2021-2026) & (US$/kg) Table 162. Asia Imipenem Sales Price by Application (2027-2032) & (US$/kg) Table 163. Asia Imipenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Imipenem Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia Imipenem Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia Imipenem Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 167. Asia Imipenem Sales by Country (2021-2026) & (kg) Table 168. Asia Imipenem Sales by Country (2027-2032) & (kg) Table 169. Asia Imipenem Sales Price by Country (2021-2026) & (US$/kg) Table 170. Asia Imipenem Sales Price by Country (2027-2032) & (US$/kg) Table 171. Japan Imipenem Revenue (2021-2032) & (US$ Million) Table 172. South Korea Imipenem Revenue (2021-2032) & (US$ Million) Table 173. India Imipenem Revenue (2021-2032) & (US$ Million) Table 174. Australia Imipenem Revenue (2021-2032) & (US$ Million) Table 175. Taiwan Imipenem Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia Imipenem Revenue (2021-2032) & (US$ Million) Table 177. SAMEA Imipenem Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Imipenem Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Imipenem Sales by Type (2021-2026) & (kg) Table 180. SAMEA Imipenem Sales by Type (2027-2032) & (kg) Table 181. SAMEA Imipenem Sales Price by Type (2021-2026) & (US$/kg) Table 182. SAMEA Imipenem Sales Price by Type (2027-2032) & (US$/kg) Table 183. SAMEA Imipenem Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Imipenem Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Imipenem Sales by Application (2021-2026) & (kg) Table 186. SAMEA Imipenem Sales by Application (2027-2032) & (kg) Table 187. SAMEA Imipenem Sales Price by Application (2021-2026) & (US$/kg) Table 188. SAMEA Imipenem Sales Price by Application (2027-2032) & (US$/kg) Table 189. SAMEA Imipenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Imipenem Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA Imipenem Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA Imipenem Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 193. SAMEA Imipenem Sales by Country (2021-2026) & (kg) Table 194. SAMEA Imipenem Sales by Country (2027-2032) & (kg) Table 195. SAMEA Imipenem Sales Price by Country (2021-2026) & (US$/kg) Table 196. SAMEA Imipenem Sales Price by Country (2027-2032) & (US$/kg) Table 197. Brazil Imipenem Revenue (2021-2032) & (US$ Million) Table 198. Argentina Imipenem Revenue (2021-2032) & (US$ Million) Table 199. Chile Imipenem Revenue (2021-2032) & (US$ Million) Table 200. Colombia Imipenem Revenue (2021-2032) & (US$ Million) Table 201. Peru Imipenem Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia Imipenem Revenue (2021-2032) & (US$ Million) Table 203. Israel Imipenem Revenue (2021-2032) & (US$ Million) Table 204. UAE Imipenem Revenue (2021-2032) & (US$ Million) Table 205. Turkey Imipenem Revenue (2021-2032) & (US$ Million) Table 206. Iran Imipenem Revenue (2021-2032) & (US$ Million) Table 207. Egypt Imipenem Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Imipenem Distributors List Table 211. Imipenem Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Imipenem Image Figure 2. Global Imipenem Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Imipenem Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sterile Type Image Figure 5. Non-sterile Type Image Figure 6. Global Imipenem Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Imipenem Market Size Share 2021 VS 2025 VS 2032 Figure 8. Injection Image Figure 9. Other Image Figure 10. Global Imipenem Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Imipenem Revenue (2021-2032) & (US$ Million) Figure 12. Global Imipenem Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Imipenem Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Imipenem Revenue Market Share by Region (2021-2032) Figure 15. Global Imipenem Sales (2021-2032) & (kg) Figure 16. Global Imipenem Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 17. Global Imipenem Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Imipenem Sales YoY (2021-2032) & (kg) Figure 19. Europe Imipenem Sales YoY (2021-2032) & (kg) Figure 20. China Imipenem Sales YoY (2021-2032) & (kg) Figure 21. Asia (Excluding China) Imipenem Sales YoY (2021-2032) & (kg) Figure 22. South America, Middle East and Africa Imipenem Sales YoY (2021-2032) & (kg) Figure 23. Global Imipenem Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Imipenem Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Imipenem Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Imipenem Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Imipenem Revenue Market Share by Type (2021-2032) Figure 29. Global Imipenem Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 30. Global Imipenem Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Imipenem Sales Market Share by Type (2021-2032) Figure 32. Global Imipenem Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Imipenem Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Imipenem Revenue Market Share by Application (2021-2032) Figure 35. Global Imipenem Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 36. Global Imipenem Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Imipenem Sales Market Share by Application (2021-2032) Figure 38. North America Imipenem Revenue Share by Type (2021-2032) Figure 39. North America Imipenem Sales Share by Type (2021-2032) Figure 40. North America Imipenem Revenue Share by Application (2021-2032) Figure 41. North America Imipenem Sales Share by Application (2021-2032) Figure 42. North America Imipenem Revenue Share by Country (2021-2032) Figure 43. North America Imipenem Sales Share by Country (2021-2032) Figure 44. Europe Imipenem Revenue Share by Type (2021-2032) Figure 45. Europe Imipenem Sales Share by Type (2021-2032) Figure 46. Europe Imipenem Revenue Share by Application (2021-2032) Figure 47. Europe Imipenem Sales Share by Application (2021-2032) Figure 48. Europe Imipenem Revenue Share by Country (2021-2032) Figure 49. Europe Imipenem Sales Share by Country (2021-2032) Figure 50. China Imipenem Revenue Share by Type (2021-2032) Figure 51. China Imipenem Sales Share by Type (2021-2032) Figure 52. China Imipenem Revenue Share by Application (2021-2032) Figure 53. China Imipenem Sales Share by Application (2021-2032) Figure 54. Asia Imipenem Revenue Share by Type (2021-2032) Figure 55. Asia Imipenem Sales Share by Type (2021-2032) Figure 56. Asia Imipenem Revenue Share by Application (2021-2032) Figure 57. Asia Imipenem Sales Share by Application (2021-2032) Figure 58. Asia Imipenem Revenue Share by Country (2021-2032) Figure 59. Asia Imipenem Sales Share by Country (2021-2032) Figure 60. SAMEA Imipenem Revenue Share by Type (2021-2032) Figure 61. SAMEA Imipenem Sales Share by Type (2021-2032) Figure 62. SAMEA Imipenem Revenue Share by Application (2021-2032) Figure 63. SAMEA Imipenem Sales Share by Application (2021-2032) Figure 64. SAMEA Imipenem Revenue Share by Country (2021-2032) Figure 65. SAMEA Imipenem Sales Share by Country (2021-2032) Figure 66. Imipenem Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Imipenem Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Sterile Type
  • Non-sterile Type
Applications
  • Injection
  • Other
Companies covered
  • Sun Pharmaceutical Industries
  • Haibin Pharmaceutical
  • Jiangxi Fushine Pharmaceutical
  • Savior Lifetec
  • HISUN Pharmaceutical
  • HISOAR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Imipenem Market by Type
  3. 1.2.1 Global Imipenem Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sterile Type
  5. 1.2.3 Non-sterile Type
  6. 1.3 Imipenem Market by Application
  7. 1.3.1 Global Imipenem Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Injection
  9. 1.3.3 Other
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Imipenem Market Dynamics
  1. 2.1 Imipenem Industry Trends
  2. 2.2 Imipenem Industry Drivers
  3. 2.3 Imipenem Industry Opportunities and Challenges
  4. 2.4 Imipenem Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Imipenem Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Imipenem Revenue by Region
  3. 3.2.1 Global Imipenem Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Imipenem Revenue by Region (2021-2026)
  5. 3.2.3 Global Imipenem Revenue by Region (2027-2032)
  6. 3.2.4 Global Imipenem Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Imipenem Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Imipenem Sales by Region
  9. 3.4.1 Global Imipenem Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Imipenem Sales by Region (2021-2026)
  11. 3.4.3 Global Imipenem Sales by Region (2027-2032)
  12. 3.4.4 Global Imipenem Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Imipenem Revenue by Manufacturers
  2. 4.1.1 Global Imipenem Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Imipenem Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Imipenem Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Imipenem Sales by Manufacturers
  6. 4.2.1 Global Imipenem Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Imipenem Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Imipenem Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Imipenem Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Imipenem Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Imipenem Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Imipenem Manufacturers, Product Type & Application
  13. 4.7 Global Imipenem Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Imipenem Market CR5 and HHI
  16. 4.8.2 2025 Imipenem Tier 1, Tier 2, and Tier 3
5 Imipenem Market by Type
  1. 5.1 Global Imipenem Revenue by Type
  2. 5.1.1 Global Imipenem Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Imipenem Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Imipenem Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Imipenem Sales by Type
  6. 5.2.1 Global Imipenem Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Imipenem Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Imipenem Sales Market Share by Type (2021-2032)
  9. 5.3 Global Imipenem Price by Type
6 Imipenem Market by Application
  1. 6.1 Global Imipenem Revenue by Application
  2. 6.1.1 Global Imipenem Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Imipenem Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Imipenem Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Imipenem Sales by Application
  6. 6.2.1 Global Imipenem Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Imipenem Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Imipenem Sales Market Share by Application (2021-2032)
  9. 6.3 Global Imipenem Price by Application
7 Company Profiles
  1. 7.1 Sun Pharmaceutical Industries
  2. 7.1.1 Sun Pharmaceutical Industries Company Information
  3. 7.1.2 Sun Pharmaceutical Industries Business Overview
  4. 7.1.3 Sun Pharmaceutical Industries Imipenem Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sun Pharmaceutical Industries Imipenem Product Portfolio
  6. 7.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 7.2 Haibin Pharmaceutical
  8. 7.2.1 Haibin Pharmaceutical Company Information
  9. 7.2.2 Haibin Pharmaceutical Business Overview
  10. 7.2.3 Haibin Pharmaceutical Imipenem Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Haibin Pharmaceutical Imipenem Product Portfolio
  12. 7.2.5 Haibin Pharmaceutical Recent Developments
  13. 7.3 Jiangxi Fushine Pharmaceutical
  14. 7.3.1 Jiangxi Fushine Pharmaceutical Company Information
  15. 7.3.2 Jiangxi Fushine Pharmaceutical Business Overview
  16. 7.3.3 Jiangxi Fushine Pharmaceutical Imipenem Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jiangxi Fushine Pharmaceutical Imipenem Product Portfolio
  18. 7.3.5 Jiangxi Fushine Pharmaceutical Recent Developments
  19. 7.4 Savior Lifetec
  20. 7.4.1 Savior Lifetec Company Information
  21. 7.4.2 Savior Lifetec Business Overview
  22. 7.4.3 Savior Lifetec Imipenem Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Savior Lifetec Imipenem Product Portfolio
  24. 7.4.5 Savior Lifetec Recent Developments
  25. 7.5 HISUN Pharmaceutical
  26. 7.5.1 HISUN Pharmaceutical Company Information
  27. 7.5.2 HISUN Pharmaceutical Business Overview
  28. 7.5.3 HISUN Pharmaceutical Imipenem Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 HISUN Pharmaceutical Imipenem Product Portfolio
  30. 7.5.5 HISUN Pharmaceutical Recent Developments
  31. 7.6 HISOAR
  32. 7.6.1 HISOAR Company Information
  33. 7.6.2 HISOAR Business Overview
  34. 7.6.3 HISOAR Imipenem Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 HISOAR Imipenem Product Portfolio
  36. 7.6.5 HISOAR Recent Developments
8 North America
  1. 8.1 North America Imipenem Market Size by Type
  2. 8.1.1 North America Imipenem Revenue by Type (2021-2032)
  3. 8.1.2 North America Imipenem Sales by Type (2021-2032)
  4. 8.1.3 North America Imipenem Price by Type (2021-2032)
  5. 8.2 North America Imipenem Market Size by Application
  6. 8.2.1 North America Imipenem Revenue by Application (2021-2032)
  7. 8.2.2 North America Imipenem Sales by Application (2021-2032)
  8. 8.2.3 North America Imipenem Price by Application (2021-2032)
  9. 8.3 North America Imipenem Market Size by Country
  10. 8.3.1 North America Imipenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Imipenem Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Imipenem Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Imipenem Market Size by Type
  2. 9.1.1 Europe Imipenem Revenue by Type (2021-2032)
  3. 9.1.2 Europe Imipenem Sales by Type (2021-2032)
  4. 9.1.3 Europe Imipenem Price by Type (2021-2032)
  5. 9.2 Europe Imipenem Market Size by Application
  6. 9.2.1 Europe Imipenem Revenue by Application (2021-2032)
  7. 9.2.2 Europe Imipenem Sales by Application (2021-2032)
  8. 9.2.3 Europe Imipenem Price by Application (2021-2032)
  9. 9.3 Europe Imipenem Market Size by Country
  10. 9.3.1 Europe Imipenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Imipenem Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Imipenem Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Imipenem Market Size by Type
  2. 10.1.1 China Imipenem Revenue by Type (2021-2032)
  3. 10.1.2 China Imipenem Sales by Type (2021-2032)
  4. 10.1.3 China Imipenem Price by Type (2021-2032)
  5. 10.2 China Imipenem Market Size by Application
  6. 10.2.1 China Imipenem Revenue by Application (2021-2032)
  7. 10.2.2 China Imipenem Sales by Application (2021-2032)
  8. 10.2.3 China Imipenem Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Imipenem Market Size by Type
  2. 11.1.1 Asia Imipenem Revenue by Type (2021-2032)
  3. 11.1.2 Asia Imipenem Sales by Type (2021-2032)
  4. 11.1.3 Asia Imipenem Price by Type (2021-2032)
  5. 11.2 Asia Imipenem Market Size by Application
  6. 11.2.1 Asia Imipenem Revenue by Application (2021-2032)
  7. 11.2.2 Asia Imipenem Sales by Application (2021-2032)
  8. 11.2.3 Asia Imipenem Price by Application (2021-2032)
  9. 11.3 Asia Imipenem Market Size by Country
  10. 11.3.1 Asia Imipenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Imipenem Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Imipenem Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Imipenem Market Size by Type
  2. 12.1.1 SAMEA Imipenem Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Imipenem Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Imipenem Price by Type (2021-2032)
  5. 12.2 SAMEA Imipenem Market Size by Application
  6. 12.2.1 SAMEA Imipenem Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Imipenem Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Imipenem Price by Application (2021-2032)
  9. 12.3 SAMEA Imipenem Market Size by Country
  10. 12.3.1 SAMEA Imipenem Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Imipenem Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Imipenem Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Imipenem Value Chain Analysis
  2. 13.1.1 Imipenem Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Imipenem Production Mode & Process
  6. 13.2 Imipenem Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Imipenem Distributors
  9. 13.2.3 Imipenem Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst